FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study

被引:0
作者
Alberto Zaniboni
Enrico Aitini
Sandro Barni
Daris Ferrari
Stefano Cascinu
Vincenzo Catalano
Giuseppe Valmadre
Domenica Ferrara
Enzo Veltri
Claudio Codignola
Roberto Labianca
机构
[1] Fondazione Poliambulanza,Medical Oncology Unit
[2] C. Poma Hospital,Medical Oncology Unit
[3] Treviglio-Caravaggio Hospital,Medical Oncology Unit
[4] S. Paolo Hospital,Medical Oncology Unit
[5] Università Politecnica delle Marche,Medical Oncology Unit
[6] Ospedali Riuniti di Ancona,Medical Oncology Unit
[7] Ospedali Riuniti Marche Nord,Medical Oncology DH
[8] Presidio San Salvatore,Medical Oncology Unit
[9] Ospedale di Sondalo,Medical Oncology Unit
[10] Ospedale San Carlo,Department of Surgery
[11] Ospedale Don Luigi di Liegro,Medical Oncology Unit
[12] Fondazione Poliambulanza,undefined
[13] Ospedali Riuniti,undefined
来源
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词
Pancreatic cancer; FOLFIRI; Chemotherapy; Second-line; Irinotecan;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1641 / 1645
页数:4
相关论文
共 176 条
  • [91] Gwyther S(undefined)undefined undefined undefined undefined-undefined
  • [92] Mooney M(undefined)undefined undefined undefined undefined-undefined
  • [93] Rubinstein L(undefined)undefined undefined undefined undefined-undefined
  • [94] Shankar L(undefined)undefined undefined undefined undefined-undefined
  • [95] Dodd L(undefined)undefined undefined undefined undefined-undefined
  • [96] Kaplan R(undefined)undefined undefined undefined undefined-undefined
  • [97] Lacombe D(undefined)undefined undefined undefined undefined-undefined
  • [98] Verweij J(undefined)undefined undefined undefined undefined-undefined
  • [99] Simon R(undefined)undefined undefined undefined undefined-undefined
  • [100] Kaplan EL(undefined)undefined undefined undefined undefined-undefined